PATENT CLAIM ANALYSIS

Application Number: 15892331
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "093710"]

Abstract:
The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.

Claim (Index 9):
The method according to  claim 8 , wherein the effector T cells and/or central memory T cells exhibit increased CD57 expression and decreased CD56 expression.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.3
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15892311', '15874718', '15800967', '14917214', '15110111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747919409525142
- 35 USC 102 Novelty (BERT): 0.5877173049422213
- Combined Prediction Score: 0.756084477351485
- Mean Citation Score: 395.835198
- Max Citation Score: 565.9608
- Similarity Product: 401.2573640625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test